Journal of Neurological Surgery Part B: Skull Base, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · J Neurol Surg B Skull Base 2025; 86(02): 234-242
DOI: 10.1055/a-2263-1778

Original Article

Morbid Obesity and Diabetes Increase the Risk of Reoperation following Microvascular Decompression: A National Surgical Quality Improvement Program Analysis of 1,303 Patients

Alper Dincer

¹Department of Neurosurgery, Tufts Medical Center, Boston, Massachusetts, United States

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

,

Joanna K. Tabor

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

,

Alexandros F. Pappajohn

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

,

Joseph O'Brien

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

,

Saul Morales-Valero

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

,

Miri Kim

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

,

Jennifer Moliterno

²Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States

› Institutsangaben

Abstract

Background Microvascular decompression (MVD) is the preferred treatment for refractory trigeminal neuralgia (TN) and hemifacial spasm (HFS). MVD provides long-lasting results for these conditions with a relatively low risk of postoperative complications. However, reoperation rates are reported up to 11%, an unacceptably high rate for an elective procedure. We determined what factors may increase the risk of reoperation among patients undergoing MVD for TN or HFS.

Methods Patient data from 2015 to 2020 were obtained from the American College of Surgeons–National Surgical Quality Improvement Program database and were included in this study if they had a procedure corresponding to an MVD with the current procedural terminology code 61458. Patient demographics, comorbidities, and outcomes were analyzed. Patients were subsequently categorized based on body mass index (BMI) and a logistic regression analysis was used to model the association of comorbidities with reoperation and its indication.

Results The overall rate of reoperation in the cohort is 3.2 and 7.2% for patients with morbid obesity (BMI ≥ 40; p = 0.006). Patients with morbid obesity were more likely to present at a younger age (50.1 vs. 57.4; p < 0.0001), have comorbidities such as hypertension (60.9 vs. 33.5%; p < 0.0001) and diabetes (16.3 vs. 7.7%; p = 0.0002), and increased procedure duration (179 vs. 164 minutes; p = 0.02). Indications for reoperation include cerebrospinal fluid (CSF) leak (31%), wound complications (19%), refractory pain (11.9), intracranial hemorrhage (4.8%), and other/unknown (33.3%). Patients with either morbid obesity or diabetes have a 2-fold increase in risk of reoperation, while having both is associated with a 5-fold risk of reoperation.

Conclusion We demonstrate morbid obesity leads to increased procedure duration and increased risk of reoperation due to wound complications and CSF leak. In these patients, alternative treatment strategies or preoperative optimization may be reasonable to reduce the risk of surgical complications and reoperation.

Keywords

Keywords

obese - pain - trigeminal neuralgia - microvascular decompression - surgical complications - reoperation

References
1 Zhao G, Sun X, Zhang Z, Yang H, Zheng X, Feng B. Clinical efficacy of MVD combined with PSR in the treatment of primary trigeminal neuralgia. Exp Ther Med 2020; 20 (02) 1582-1588
2 Menna G, Battistelli M, Rapisarda A. et al. Factors related to hemifacial spasm recurrence in patients undergoing microvascular decompression-a systematic review and meta-analysis. Brain Sci 2022; 12 (05) 583
3 Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord 2011; 26 (09) 1582-1592
4 Broggi M, Acerbi F, Ferroli P, Tringali G, Schiariti M, Broggi G. Microvascular decompression for neurovascular conflicts in the cerebello-pontine angle: which role for endoscopy?. Acta Neurochir (Wien) 2013; 155 (09) 1709-1716
5 Lee MH, Lee JA, Park K. Different roles of microvascular decompression in hemifacial spasm and trigeminal neuralgia. J Neurol Surg B Skull Base 2019; 80 (05) 511-517
6 Yamaki T, Hashi K, Niwa J. et al. Results of reoperation for failed microvascular decompression. Acta Neurochir (Wien) 1992; 115 (1-2): 1-7
7 Tatli M, Satici O, Kanpolat Y, Sindou M. Various surgical modalities for trigeminal neuralgia: literature study of respective long-term outcomes. Acta Neurochir (Wien) 2008; 150 (03) 243-255
8 Park CK, Park BJ. Surgical treatment for trigeminal neuralgia. J Korean Neurosurg Soc 2022; 65 (05) 615-621
9 Xia L, Zhong J, Zhu J. et al. Effectiveness and safety of microvascular decompression surgery for treatment of trigeminal neuralgia: a systematic review. J Craniofac Surg 2014; 25 (04) 1413-1417
10 Barker II FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 1996; 334 (17) 1077-1083
11 Rogers CL, Shetter AG, Fiedler JA, Smith KA, Han PP, Speiser BL. Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of The Barrow Neurological Institute. Int J Radiat Oncol Biol Phys 2000; 47 (04) 1013-1019
12 Cohen-Gadol AA. Microvascular decompression surgery for trigeminal neuralgia and hemifacial spasm: naunces of the technique based on experiences with 100 patients and review of the literature. Clin Neurol Neurosurg 2011; 113 (10) 844-853
13 Cote DJ, Dasenbrock HH, Gormley WB, Smith TR, Dunn IF. Adverse events after microvascular decompression: a national surgical quality improvement program analysis. World Neurosurg 2019; 128: e884-e894
14 Sekula Jr RF, Frederickson AM, Jannetta PJ, Quigley MR, Aziz KM, Arnone GD. Microvascular decompression for elderly patients with trigeminal neuralgia: a prospective study and systematic review with meta-analysis. J Neurosurg 2011; 114 (01) 172-179
15 Jiao L, Ye H, Lv J. et al. A systematic review of repeat microvascular decompression for recurrent or persistent trigeminal neuralgia. World Neurosurg 2022; 158: 226-233
16 Khattab MH, Sherry AD, Kim E. et al. Body mass index and response to stereotactic radiosurgery in the treatment of refractory trigeminal neuralgia: a retrospective cohort study. J Radiosurg SBRT 2020; 6 (04) 253-261
17 Arnone GD, Esfahani DR, Papastefan S. et al. Diabetes and morbid obesity are associated with higher reoperation rates following microvascular decompression surgery: An ACS-NSQIP analysis. Surg Neurol Int 2017; 8: 268
18 Alford EN, Chagoya G, Elsayed GA. et al. Risk factors for wound-related complications after microvascular decompression. Neurosurg Rev 2021; 44 (02) 1093-1101
19 Liao JJ, Cheng WC, Chang CN. et al. Reoperation for recurrent trigeminal neuralgia after microvascular decompression. Surg Neurol 1997; 47 (06) 562-568 , discussion 568–570
20 Sellers MM, Merkow RP, Halverson A. et al. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2013; 216 (03) 420-427
21 Khuri SF, Daley J, Henderson W. et al; National VA Surgical Quality Improvement Program. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg 1998; 228 (04) 491-507
22 Khuri SF, Henderson WG, Daley J. et al; Principal Site Investigators of the Patient Safety in Surgery Study. The patient safety in surgery study: background, study design, and patient populations. J Am Coll Surg 2007; 204 (06) 1089-1102
23 Khuri SF, Henderson WG, Daley J. et al; Principal Investigators of the Patient Safety in Surgery Study. Successful implementation of the Department of Veterans Affairs' National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study. Ann Surg 2008; 248 (02) 329-336
24 Sandy-Hodgetts K, Carville K, Leslie GD. Determining risk factors for surgical wound dehiscence: a literature review. Int Wound J 2015; 12 (03) 265-275
25 Terranova A. The effects of diabetes mellitus on wound healing. Plast Surg Nurs 1991; 11 (01) 20-25
26 Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am 2001; 15 (02) 407-421 , viii
27 Houdek MT, Griffin AM, Ferguson PC, Wunder JS. Morbid obesity increases the risk of postoperative wound complications, infection, and repeat surgical procedures following upper extremity limb salvage surgery for soft tissue sarcoma. Hand (N Y) 2019; 14 (01) 114-120
28 Bamgbade OA, Rutter TW, Nafiu OO, Dorje P. Postoperative complications in obese and nonobese patients. World J Surg 2007; 31 (03) 556-560 , discussion 561
29 Doyle SL, Lysaght J, Reynolds JV. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev 2010; 11 (12) 875-886
30 Seyni-Boureima R, Zhang Z, Antoine MMLK, Antoine-Frank CD. A review on the anesthetic management of obese patients undergoing surgery. BMC Anesthesiol 2022; 22 (01) 98
31 Tuleasca C, Régis J, Sahgal A. et al. Stereotactic radiosurgery for trigeminal neuralgia: a systematic review. J Neurosurg 2018; 130 (03) 733-757
32 Kondziolka D, Perez B, Flickinger JC, Habeck M, Lunsford LD. Gamma knife radiosurgery for trigeminal neuralgia: results and expectations. Arch Neurol 1998; 55 (12) 1524-1529
33 Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care 2014; 37 (03) 611-616
34 Hart A, Goffredo P, Carroll R. et al. Optimizing bariatric surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures. Surg Endosc 2021; 35 (08) 4618-4623
35 Roth SG, Chanbour H, Gupta R. et al. Optimal hemoglobin A1C target in diabetics undergoing elective cervical spine surgery. Spine J 2022; 22 (07) 1149-1159